Microbiome in Cancer: An Exploration of Carcinogenesis, Immune Responses and Immunotherapy

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Aug 25

PMID 36003378

Authors

Pei Zhou

Yawen Hu

Xiaoyan Wang

Luxuan Shen

Xinghao Liao

Yajuan Zhu

Jiadong Yu

Fulei Zhao

Yi Zhou

Hengshui Shen

Jiong Li

Affiliations

Soon will be listed here.

Abstract

Cancer is a major disease endangering human health. More and more studies have shown that microorganisms play an extremely important role in the occurrence, development and treatment of tumors. As a very promising tumor treatment strategy, immunotherapy has also been proved to have a great relationship with microorganisms. Here, the authors review the contribution of the microbiota to cancer and the research on its impact on cancer immunotherapy. We also highlight the possible mechanism of their interaction and outlined the potential application of microbiota in tumor immunotherapy.

Citing Articles

An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid.

Thomsen M, Vemuri R, Huygens F, Clarke S, Vitetta L Inflammopharmacology. 2024; 32(4):2317-2335.

PMID: 38926298 PMC: 11300539. DOI: 10.1007/s10787-024-01503-1.

Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies.

Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X Imeta. 2024; 3(1):e156.

PMID: 38868510 PMC: 10989143. DOI: 10.1002/imt2.156.

The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions.

Fu Y, Li J, Cai W, Huang Y, Liu X, Ma Z Acta Pharm Sin B. 2024; 14(4):1560-1591.

PMID: 38572104 PMC: 10985043. DOI: 10.1016/j.apsb.2023.11.018.

Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities.

Kim S, Park M, Choi A, Yoo S Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256945 PMC: 10819128. DOI: 10.3390/ph17010112.

A Comparison of the Oral Microbiota in Healthy Dogs and Dogs with Oral Tumors.

Lisjak A, Correa Lopes B, Pilla R, Nemec A, Suchodolski J, Tozon N Animals (Basel). 2023; 13(23).

PMID: 38066947 PMC: 10705671. DOI: 10.3390/ani13233594.

References

Bakhti S, Latifi-Navid S . Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis. BMC Microbiol. 2021; 21(1):258. PMC: 8461988. DOI: 10.1186/s12866-021-02315-x. View

Han K, Nam J, Xu J, Sun X, Huang X, Animasahun O . Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel. Nat Biomed Eng. 2021; 5(11):1377-1388. PMC: 8595497. DOI: 10.1038/s41551-021-00749-2. View

Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

Kidane D . Molecular Mechanisms of -Induced DNA Double-Strand Breaks. Int J Mol Sci. 2018; 19(10). PMC: 6213211. DOI: 10.3390/ijms19102891. View

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

Yang W, Yu T, Huang X, Bilotta A, Xu L, Lu Y . Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020; 11(1):4457. PMC: 7478978. DOI: 10.1038/s41467-020-18262-6. View

Hinshaw D, Shevde L . The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019; 79(18):4557-4566. PMC: 6744958. DOI: 10.1158/0008-5472.CAN-18-3962. View

Dominguez-Bello M, Godoy-Vitorino F, Knight R, Blaser M . Role of the microbiome in human development. Gut. 2019; 68(6):1108-1114. PMC: 6580755. DOI: 10.1136/gutjnl-2018-317503. View

Nastasi C, Candela M, Bonefeld C, Geisler C, Hansen M, Krejsgaard T . The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep. 2015; 5:16148. PMC: 4635422. DOI: 10.1038/srep16148. View

10.

Baruch E, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L . Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2020; 371(6529):602-609. DOI: 10.1126/science.abb5920. View

11.

Chen D, Wu J, Jin D, Wang B, Cao H . Fecal microbiota transplantation in cancer management: Current status and perspectives. Int J Cancer. 2018; 145(8):2021-2031. PMC: 6767494. DOI: 10.1002/ijc.32003. View

12.

Boesch M, Baty F, Rothschild S, Tamm M, Joerger M, Fruh M . Tumour neoantigen mimicry by microbial species in cancer immunotherapy. Br J Cancer. 2021; 125(3):313-323. PMC: 8329167. DOI: 10.1038/s41416-021-01365-2. View

13.

Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z . Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy. Front Immunol. 2021; 11:612202. PMC: 7817884. DOI: 10.3389/fimmu.2020.612202. View

14.

Marzano M, Fosso B, Piancone E, Defazio G, Pesole G, De Robertis M . Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer. Cancers (Basel). 2021; 13(5). PMC: 7957811. DOI: 10.3390/cancers13050996. View

15.

Branquinho D, Freire P, Sofia C . NOD2 mutations and colorectal cancer - Where do we stand?. World J Gastrointest Surg. 2016; 8(4):284-93. PMC: 4840167. DOI: 10.4240/wjgs.v8.i4.284. View

16.

Keogh C, Rude K, Gareau M . Role of pattern recognition receptors and the microbiota in neurological disorders. J Physiol. 2021; 599(5):1379-1389. PMC: 8221416. DOI: 10.1113/JP279771. View

17.

Boesch M, Baty F, Albrich W, Flatz L, Rodriguez R, Rothschild S . Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology. 2021; 10(1):1988403. PMC: 8667931. DOI: 10.1080/2162402X.2021.1988403. View

18.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

19.

Rubinstein M, Wang X, Liu W, Hao Y, Cai G, Han Y . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14(2):195-206. PMC: 3770529. DOI: 10.1016/j.chom.2013.07.012. View

20.

Geiger R, Rieckmann J, Wolf T, Basso C, Feng Y, Fuhrer T . L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. Cell. 2016; 167(3):829-842.e13. PMC: 5075284. DOI: 10.1016/j.cell.2016.09.031. View